🇺🇸 SECBioCryst Pharmaceuticals Inc.Codex · 实盘不做把握 6/10
北京时间·🕒 发布 19:01:21时区推断·⟳ 抓取 19:23:21·⚡ 决策 08-04 19:08:01 −15m20s·84.2 天前
BioCryst提交8-K/A修正早前关闭伯明翰研发中心和终止内部发现项目的披露
当前抓取到的是SEC目录页，能确认BioCryst在2026-08-04盘前提交8-K/A，但核心退出计划已在2026-06-29由公司公告和8-K披露。
📄 原文BioCryst Pharmaceuticals Inc.↗ 原文
Item 2.05
Directory List of /Archives/edgar/data/882796/000117184326005168 Search Options Skip to Main Content About What We Do C…
不做 BioCryst Pharmaceuticals（BCRX.US）
核心关闭研发中心和费用指引改善已于2026-06-29官方披露并广泛传播，当前8-K/A目录页未显示新的可量化正负增量；无明确edge，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- 公司6月29日8-K披露董事会6月25日批准终止内部发现项目并关闭伯明翰研发中心的计划。
- 公司新闻稿披露关闭研发设施、完成navenibart三期入组、解决ORLADEYO儿童剂型制造延迟，并下调2026年非GAAP经营费用指引。
- 行业媒体当天已报道BioCryst结束内部发现项目并转向外部创新合作，说明核心信息早已扩散。
- 当前SEC目录显示BioCryst提交8-K/A文件f8ka_080326.htm，属于对前述事项的修正披露；目录页未提供可直接改变交易判断的新金额或经营条款。
关键理由
- 当前抓取到的是SEC目录页，能确认BioCryst在2026-08-04盘前提交8-K/A，但核心退出计划已在2026-06-29由公司公告和8-K披露。
- 6月29日公告已披露关闭伯明翰研发中心、终止内部发现项目、2026年非GAAP经营费用指引下调至4.20亿-4.40亿美元且收入指引不变，当前事件缺少新的可交易增量。
- 该类8-K/A修正更像对既有重组事项的补充披露，无法形成明确短线同向LONG或强SHORT催化。
主要风险
- 若8-K/A正文新增披露的退出成本显著高于市场预期，需由后续完整文本信号重新评估。
原文全文
展开原文 · 1,618 字
Directory List of /Archives/edgar/data/882796/000117184326005168
Search Options
Skip to Main Content
About
What We Do
Commissioners
Securities Laws
Reports
Careers
Contact
Divisions
Corporation Finance
Enforcement
Investment Management
Risk, Strategy and Innovation
Trading and Markets
National Exam Program
All Divisions and Offices
Litigation Releases
Administrative Proceedings
Opinions and Adjudicatory Orders
Accounting and Auditing
Trading Suspensions
How Investigations Work
Administrative Law Judges
Regulation
Proposed Rules
Final Rules
Interim Final Temporary Rules
Other Orders and Notices
Self-Regulatory Organizations
Staff Interpretations
Education
Investor.gov
Check Out a Broker or Adviser
Investor Alerts and Bulletins
Fast Answers
File a Tip or Complaint
Publications
Filings
Quick EDGAR Tutorial
Company Filings Search
Descriptions of SEC Forms
Requesting Public Documents
News
Press Releases
What's New
Upcoming Events
News Digest
Webcasts
Special Studies
Speeches and Public Statements
Testimony
Directory Listing /Archives/edgar/data/882796/000117184326005168
Parent Directory
Name
Size
Last Modified
0001171843-26-005168-index-headers.html
2026-08-04 07:01:21
0001171843-26-005168-index.html
0001171843-26-005168.txt
0001171843-26-005168-xbrl.zip
11328
bcrx-20260625.xsd
3038
bcrx-20260625_lab.xml
34239
bcrx-20260625_pre.xml
22374
f8ka_080326.htm
24381
f8ka_080326_htm.xml
3770
FilingSummary.xml
1639
MetaLinks.json
39713
R1.htm
41531
report.css
2766
Show.js
1084
Site Map
Accessibility
Contracts
Privacy
Inspector General
FOIA
No FEAR Act & EEO Data
Open Government
Plain Writing
Links
USA.gov
Search Options
Skip to Main Content
About
What We Do
Commissioners
Securities Laws
Reports
Careers
Contact
Divisions
Corporation Finance
Enforcement
Investment Management
Risk, Strategy and Innovation
Trading and Markets
National Exam Program
All Divisions and Offices
Litigation Releases
Administrative Proceedings
Opinions and Adjudicatory Orders
Accounting and Auditing
Trading Suspensions
How Investigations Work
Administrative Law Judges
Regulation
Proposed Rules
Final Rules
Interim Final Temporary Rules
Other Orders and Notices
Self-Regulatory Organizations
Staff Interpretations
Education
Investor.gov
Check Out a Broker or Adviser
Investor Alerts and Bulletins
Fast Answers
File a Tip or Complaint
Publications
Filings
Quick EDGAR Tutorial
Company Filings Search
Descriptions of SEC Forms
Requesting Public Documents
News
Press Releases
What's New
Upcoming Events
News Digest
Webcasts
Special Studies
Speeches and Public Statements
Testimony
Directory Listing /Archives/edgar/data/882796/000117184326005168
Parent Directory
Name
Size
Last Modified
0001171843-26-005168-index-headers.html
2026-08-04 07:01:21
0001171843-26-005168-index.html
0001171843-26-005168.txt
0001171843-26-005168-xbrl.zip
11328
bcrx-20260625.xsd
3038
bcrx-20260625_lab.xml
34239
bcrx-20260625_pre.xml
22374
f8ka_080326.htm
24381
f8ka_080326_htm.xml
3770
FilingSummary.xml
1639
MetaLinks.json
39713
R1.htm
41531
report.css
2766
Show.js
1084
Site Map
Accessibility
Contracts
Privacy
Inspector General
FOIA
No FEAR Act & EEO Data
Open Government
Plain Writing
Links
USA.gov
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。